Search clinical trials for: Modulation of FiO2

Total 10000 results

Universitaire Ziekenhuizen KU Leuven
Research Foundation Flanders

Terminated

Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction (EXTRACT-NOAC)

Tooth Extraction

Belgium
Asociación para Evitar la Ceguera en México

Terminated

Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Choroidal Neovascularization | Angioid Streaks

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Intravitreal Bevacizumab for Diabetic Retinopathy

Proliferative Diabetic Retinopathy | Severe Nonproliferative | Active Photocoagulated Diabetic Retinopathy

Mexico
University of Bonn

Completed

Effects of Xanthohumol on Resting Energy Expenditure and Substrate Oxidation in Healthy Women

Resting Energy Expenditure

Germany
Ophthotech Corporation

Withdrawn

ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Idiopathic Polypoidal Choroidal Vasculopathy

United States
Leiden University Medical Center

Completed

Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients

COVID-19 | Heparin Overdose of Undetermined Intent

Netherlands
Adverum Biotechnologies, Inc.

Completed

ADVM-022 Intravitreal Gene Therapy for Wet AMD (OPTIC)

Neovascular Age-related Macular Degeneration | Wet Age-related Macular Degeneration

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Bayer
Regeneron Pharmaceuticals

Completed

Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients (ASTERIA)

Wet Age-related Macular Degeneration

Switzerland
Abramson Cancer Center of the University of Pennsylvania

Completed

Maintenance Lenalidomide in Lymphoma

Lymphoma

United States
University of Zimbabwe
Fogarty International Center of the National Institute of Health

Completed

The Efficacy of Tranexamic Acid in Preventing Postpartum Haemorrhage After Caesarean Section (ETAPPH)

Postpartum Hemorrhage

Zimbabwe
Northwestern University

Withdrawn

Tranexamic Acid (TXA) in Hip Arthroscopy

Hip Pain Chronic | Blood Loss | Hip Injuries | Femoro Acetabular Impingement | Hip Impingement Syndrome

United States
KK Women's and Children's Hospital

Completed

Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section

Postpartum Hemorrhage | Tranexamic Acid

Singapore
University of California, Irvine
Beckman Laser Institute University of California Irvine

Withdrawn

Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks

Port Wine Stain
Azidus Brasil

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

Healthy

Brazil
Hebei Medical University Third Hospital

Completed

Anti-fibrinolytic and Anti-inflammatory Effects of Local Infiltration of Tranexamic Acid in Patients With Calcaneal Fractures

Fibrinolysis | Fracture | Tranexamic Acid | Inflammatory

China
Beijing Tiantan Hospital
Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd; The Place Pharmaceutical(Jiangsu)...

Active, not recruiting

Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）

Acute Ischemic Stroke

China
University of California, Los Angeles
Regeneron Pharmaceuticals

Completed

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy (IAI-OCTA)

Wet Macular Degeneration

United States
West Penn Allegheny Health System

Withdrawn

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Glioblastoma | Optic Neuropathy
Tasly Biopharmaceuticals Co., Ltd.

Completed

Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)

Acute Ischaemic Stroke

China
Novartis Pharmaceuticals

Completed

Canadian Treat and Extend Analysis Trial With Ranibizumab (CAN-TREAT)

wetAMD

Canada
Andrew G Hill, MBChB, MD (Thesis), EdD, FACS, FRACS

Completed

Tranexamic Acid in Knee Joint Surgery (TRACKS)

Osteoarthritis

New Zealand
Federico II University

Completed

Evaluation of Retinal and Vascular Features in Radiation Maculopathy After Intravitreal Injections of Ranibizumab

Radiation Maculopathy
Vascular Biogenics Ltd. operating as VBL Therapeutics

Completed

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme

Israel, United States
Poitiers University Hospital

Completed

Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

Naive Patients With Uncomplicated Proliferative Diabetic Retinopathy

France
Brown University
Memorial Hospital of Rhode Island; Roger Williams Medical Center

Completed

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Liver Cancer

United States
University Medical Center Groningen

Completed

FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW (FLASH)

Soft Tissue Sarcoma

Netherlands
Sun Yat-sen University

Unknown

Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer

Non Small Cell Lung Cancer | Bevacizumab | Brain Metastases | Sintilimab

China
Celgene

Completed

A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan

Multiple Myeloma

Taiwan
Celgene

Completed

MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry (MORE)

Myelodysplastic Syndrome

Italy
Celgene

Completed

Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Minia University

Completed

Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) (DME)

Diabetic Macular Edema

Egypt
University of Rijeka

Completed

Neuroinflammatory Response in Patients With ICH and IVH Treated With rtPA

Brain Injuries | Intraventricular Hemorrhage | Hypertensive Intracerebral Hemorrhage
Pusan National University Hospital
Novartis

Unknown

Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study) (VIBIM)

Macular Edema, Diabetic

Korea, Republic of
Changhua Christian Hospital

Completed

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Choroidal Neovascularization | Punctate Inner Choroidopathy

Taiwan
Associazione Qol-one

Terminated

Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q

Myelodysplastic Syndromes

France, Italy, Greece
Abramson Cancer Center of the University of Pennsylvania

Completed

CRLX101 Plus Bevacizumab in Advanced RCC

Renal Cell Carcinoma

United States
M.D. Anderson Cancer Center
Celgene

Completed

Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older

Leukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL

United States
Beijing Hospital

Unknown

Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease

Non-small Cell Lung Cancer Metastatic
Hoffmann-La Roche

Completed

An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases (PICASSO)

Colorectal Cancer

France
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Unknown

Pharmacokinetics and Safety Study of ASKB1202 in Chinese Healthy Subjects

Healthy
GWT-TUD GmbH
Novartis

Unknown

Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema (ReCaLL)

Diabetic Macular Edema

Germany
University of Zurich

Completed

Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

Colorectal Liver Metastases

Switzerland, France, Spain
Seoul National University Hospital
Novartis

Unknown

Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose

Age-related Macular Degeneration
St. Joseph's Healthcare Hamilton
LEO Pharma; Heart and Stroke Foundation of Ontario

Terminated

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Venous Thrombosis | Pulmonary Embolism

Canada
Samsung Medical Center

Unknown

Use of Transexamic Acid in Hip Replacement

Bleeding | Transfusion Related Complication

Korea, Republic of
PD. Dr. med. Armin Wolf
University Hospital, Bonn

Unknown

Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas (PEARL)

Central Retinal Vein Occlusion With Macular Edema
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer

Belgium, France, Germany, Spain, Sweden, Estonia, Portugal, Austria, Switzerland, Denmark, Czech Republic, Finland, Saudi Arabia, Netherlands, Norway
Paul Monk
Genentech, Inc.

Terminated

Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer

United States
Ferring Pharmaceuticals

Completed

Efficacy and Safety of XP12B in Women With Menorrhagia

Menorrhagia | Heavy Menstrual Bleeding

United States

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations